178 related articles for article (PubMed ID: 15635636)
1. Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments.
Łempicka E; Derdowska I; Kowalczyk W; Dawidowska O; Prahl A; Janecki M; Jasiński T; Trzeciak HI; Lammek B
J Pept Sci; 2005 Feb; 11(2):91-6. PubMed ID: 15635636
[TBL] [Abstract][Full Text] [Related]
2. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
3. Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
Kowalczyk W; Prahl A; Derdowska I; Sobolewski D; Olejnik J; Zabrocki J; Borovicková L; Slaninová J; Lammek B
J Med Chem; 2006 Mar; 49(6):2016-21. PubMed ID: 16539389
[TBL] [Abstract][Full Text] [Related]
4. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
[TBL] [Abstract][Full Text] [Related]
5. Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.
Derdowska I; Prahl A; Kowalczyk W; Janecki M; Melhem S; Trzeciak HI; Lammek B
Eur J Med Chem; 2005 Jan; 40(1):63-8. PubMed ID: 15642410
[TBL] [Abstract][Full Text] [Related]
6. Biologically active analogues of arginine vasopressin containing conformationally restricted dipeptide fragments.
Lammek B; Czaja M; Derdowska I; Lempicka E; Sikora P; Szkróbka W; Trzeciak HI
J Pept Res; 1998 Feb; 51(2):149-54. PubMed ID: 9516050
[TBL] [Abstract][Full Text] [Related]
7. The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
Kowalczyk W; Sobolewski D; Prahl A; Derdowska I; Borovicková L; Slaninová J; Lammek B
J Med Chem; 2007 Jun; 50(12):2926-9. PubMed ID: 17500550
[TBL] [Abstract][Full Text] [Related]
8. Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonists.
Manning M; Cheng LL; Stoev S; Klis W; Nawrocka E; Olma A; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1997; 3(1):31-46. PubMed ID: 9230469
[TBL] [Abstract][Full Text] [Related]
9. Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
Kowalczyk W; Prahl A; Derdowska I; Dawidowska O; Slaninová J; Lammek B
J Med Chem; 2004 Nov; 47(24):6020-4. PubMed ID: 15537356
[TBL] [Abstract][Full Text] [Related]
10. Analogues of arginine vasopressin modified in the N-terminal part of the molecule with enantiomers of N-methylphenylalanine.
Kowalczyk W; Derdowska I; Dawidowska O; Prahl A; Hartrodt B; Neubert K; Slaninová J; Lammek B
J Pept Res; 2004 May; 63(5):420-5. PubMed ID: 15140159
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
[TBL] [Abstract][Full Text] [Related]
13. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
Varga C; Somlai C; Baláspiri L; László FA
Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and some pharmacological properties of new V1/V2 antagonists of arginine-vasopressin with structural changes at their N-terminals.
Lammek B; Konieczna E; Wierzba T; Wang YX; Gavras H
Pol J Pharmacol Pharm; 1992; 44(2):179-86. PubMed ID: 1409118
[TBL] [Abstract][Full Text] [Related]
15. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
[TBL] [Abstract][Full Text] [Related]
16. Analogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motif.
Sobolewski D; Prahl A; Derdowska I; Slaninová J; Kaczmarek K; Zabrocki J; Lammek B
J Pept Sci; 2007 Feb; 13(2):128-32. PubMed ID: 17146804
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and some pharmacological properties of three new analogues of arginine-vasopressin modified in positions 1,2,4 and 9.
Lammek B; Derdowska I; Melin P
Pol J Pharmacol Pharm; 1989; 41(1):97-102. PubMed ID: 2587442
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 8-D-arginine vasopressin analogues, modified in position 1 as antagonists of the vasopressor response to the parent hormone.
Lammek B; Derdowska I; Melin P
Pol J Pharmacol Pharm; 1988; 40(4):423-8. PubMed ID: 3222181
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
